AXA SA (OTCMKTS:AXAHY) Receives $29.00 Consensus Price Target from Brokerages

Shares of AXA SA (OTCMKTS:AXAHY) have earned a consensus recommendation of “Buy” from the twelve brokerages that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company.

A number of equities analysts have issued reports on AXAHY shares. Societe Generale restated a “buy” rating on shares of AXA in a report on Wednesday, April 28th. Zacks Investment Research cut AXA from a “buy” rating to a “hold” rating in a report on Friday, July 16th. Morgan Stanley cut AXA from an “overweight” rating to an “equal weight” rating in a report on Wednesday. Royal Bank of Canada restated an “outperform” rating on shares of AXA in a report on Wednesday, March 24th. Finally, UBS Group reaffirmed a “neutral” rating on shares of AXA in a research report on Tuesday, June 29th.

Shares of AXA stock traded up $0.57 on Thursday, reaching $25.68. 68,267 shares of the company’s stock were exchanged, compared to its average volume of 128,204. The firm has a market cap of $62.01 billion, a P/E ratio of 12.17, a P/E/G ratio of 0.38 and a beta of 1.44. AXA has a 52 week low of $15.57 and a 52 week high of $28.86. The business has a 50-day moving average price of $26.70. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.14.

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in six segments: France, Europe, Asia, AXA XL, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

See Also: Growth and Income Funds

Analyst Recommendations for AXA (OTCMKTS:AXAHY)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.